Company ProfilePremium

THE CODI Co., Ltd. (formerly CODI-M Co., LTD.)

Company Profile Analysis

Ticker: 224060.KQ주식회사 더코디

ESOMAR 23 Corporate BadgeISO Certifications Badge
THE CODI Co., Ltd. - Company showcase

Year Founded & Workforce

1999

30 Employees

THE CODI Co., Ltd. logo

THE CODI Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

THE CODI Co., Ltd. Overview

THE CODI is a Cheonan-based micro-cap equipment and components maker. It began as a Samsung-qualified supplier of semiconductor and flat-panel-display process tools: wafer cleaning, photoresist coating and developing, back-end bonding, and the hot-plate/cool-plate (HP/CP) glass-drying units it says it has supplied exclusively to Samsung Electronics since 2010. Since 2017 it has been reshaped repeatedly by changes of control. It pivoted into a "bio platform" (subsidiaries PharmaWorks and Cellforium). It absorbed a 1973-founded coil/transformer maker (Daeshin Electronics, merged July 2024), plus small insulation and electrical-equipment companies. It also consolidated real-estate development vehicles that now carry about KRW 39.5 bn of development land on its balance sheet. The core equipment business is sub-scale: consolidated revenue was KRW 25.3 bn in FY2025, with persistent operating losses since 2016. Leverage is high (liabilities about 5.7x equity at FY2025, about 14.8x at June 2026). A contested, repeatedly delayed change of control is tied to a proposed pivot into robotics and AI. The equity is best characterised as a governance-driven special situation rather than an equipment growth story.


Company's own description (from DART filings and IPO materials, paraphrased)

The company describes itself, in its filings and vendor-reproduced business summaries, as a manufacturer and seller of semiconductor equipment, LCD equipment and OLED equipment, established in July 1999. It names PharmaWorks and Cellforium as its principal subsidiaries and says most revenue comes from the semiconductor division. As a new business, it plans to build an "open-innovation bio platform." Under this platform it would continuously source drug-development pipelines in Korea and abroad and rapidly co-develop or license them out to global pharmaceutical companies (Alphasquare reproduction of the business summary; Simply Wall St). The registry-based business description (Saramin) lists:

  • electronic components: high-frequency coils, transformers and SMD inductors;

  • equipment for manufacturing semiconductors and flat-panel displays.

The KRX industry code is electronic coils, transformers and other electronic inductor manufacturing. The articles of incorporation list 85 business purposes, headed by "manufacture and sale of exposure equipment (노광기) for PCB, LCD and PDP" (TheVC).

At its December 2015 IPO, the company (then CEO Lee Woo-suk) described its core products as follows (Edaily IPO interview, Dec-2015):

  • front-end semiconductor equipment for cleaning, photoresist coating and developing;

  • back-end bonding (adhesion) equipment;

  • FPD HP/CP equipment for drying glass.

It claimed the ability to support 7 of 20 semiconductor process steps once its etch, characterization-test and final-test tools under development were included. It also said it had secured capacity of about 1.5x its then-current revenue to serve Samsung's Pyeongtaek fab and Chinese panel makers (BOE, Tianma).

Independent characterisation

EngineWhat it doesEvidence of scaleAssessment
Semiconductor & display equipmentWet/track-type equipment (cleaning, coat/develop), bonding equipment, HP/CP thermal units, exposure equipment"Semiconductor [products]" = 40.09% of FY2025 revenue (≈KRW 10.1 bn); "Display [products]" = 0.09%Legacy core; customer concentration on Samsung Electronics / Samsung Display (Aju News, Sep-2026)
Electronic componentsHigh-frequency coils, transformers, SMD inductors (ex-Daeshin Electronics, now the Gumi branch; Tianjin subsidiary)Included in "Other [products etc.]" = 59.83% of FY2025 revenue (≈KRW 15.1 bn, shared with other lines)Low-margin commodity magnetics; accounts for the post-2024 revenue uplift
Bio / healthcarePharmaWorks (100%) and Cellforium (70%). Therapeutic programs reportedly target Zika/MERS, glaucoma, non-alcoholic fatty liver disease, chronic kidney disease, and immunotherapy for cancer/inflammatory diseaseNo disclosed revenue; Simply Wall St business descriptionOption value only; bio plant and acquisitions delayed for lack of funding (IB Tomato, Apr-2026)
Real-estate development vehiclesRoad One Real Estate Fund No.1 PEF (99.49%), Marine One Development (consolidated via CB holdings), E&K Consortium (99.96%), Kingdom ForeKRW 39.5 bn of development land (용지) in inventory at FY2025 and June 2026 (Valueline)The largest single asset class on the balance sheet; illiquid; linked by press reports to the former Sambu Construction chairman's family

THE CODI today is a holding-style conglomerate of small, loss-making businesses wrapped around a legacy Samsung equipment supplier. Four economic engines can be identified:

Business model / revenue model. Revenue is almost entirely product sales (equipment and components). No subscription, licensing or recurring-service revenue is disclosed. Equipment revenue is project-based and recognised around customer acceptance (검수). Press coverage notes that revenue swings with customer capex timing and acceptance dates (JobPost, Oct-2026). Equipment is sold to semiconductor and display fabs. Components are sold to electronics/power-supply OEMs (customer names for components are not disclosed).

Value-chain position. THE CODI is a tier-2/tier-3 domestic tool supplier. It supplies peripheral process modules (thermal plates, wet-process and bonding stations) rather than critical lithography/etch/deposition tools. It is a price-taker to Samsung and relies on Samsung's line investment cycles (Pyeongtaek, Godeok, Onyang, Xi'an were cited at IPO).

End-markets. Memory and foundry semiconductor fabs; OLED/LCD display fabs; general electronics (coils/transformers); and prospectively biopharma and, if the pending control change completes, robotics/AI.

Strategy

The company publishes no investor-day material, medium-term plan or financial targets. Stated strategic themes, paraphrased from filings and company statements:

  1. "Two businesses" strategy (2017–present). Keep the semiconductor equipment business while building a bio business through an open-innovation in-licensing/out-licensing platform (Newsis, Dec-2017; company summary).

  2. Normalisation via sale of control (Dec 2024–present). The company publicly committed to a sale of the largest shareholder's stake or a new-share sale to normalise management (Seoul Economic TV, Jul-2025). The deadline has been extended to 31 Dec 2026 (Green Economy).

  3. Robotics/AI pivot (Sep 2026–present). Linked to the proposed Pantos takeover. Elements: expand the articles to cover service/humanoid robots, drones, RaaS, AI SaaS, AI chips and data centers; use the KRW 30 bn CB (since withdrawn) to acquire securities of other companies (Dealsite, Oct-2026). Market commentators speculated about cooperation with LG-family companies, but no agreement has been disclosed (Aju News).

  4. Bio plant and acquisitions (2026). Funding from the spring-2026 placement/CB was earmarked for a bio-production facility and an acquisition. Both were delayed when payments slipped (IB Tomato, Apr-2026).

Initiatives in the last 24 months:

Cost programs, ESG commitments, guidance: none disclosed.

Products & Services

The company publishes no current product catalog with specifications or pricing. The list below is reconstructed from the IPO description (2015), the registry business description, the articles of incorporation and vendor summaries. Launch years, specifications and pricing are n/d unless stated.

Semiconductor equipment (≈40% of FY2025 revenue)

ProductDescriptionTarget customerNotes / flagship statusSource
Wafer cleaning equipmentFront-end wet cleaning toolsMemory/foundry fabs (Samsung Electronics)Core front-end line at IPOEdaily (2015); Aju News (2026)
Photoresist coating & developing equipmentFront-end track-type process modulesSamsung ElectronicsCore at IPOEdaily (2015)
Bonding (adhesion) equipmentBack-end packaging/bonding process tool; first deliveries April 2015 to Samsung Onyang and Xi'anSamsung back-end linesGrowth product at IPOEdaily (2015)
Etch, characterization-test and final-test equipmentIn development or planned at IPO (2015)FabsCommercial status today n/dEdaily (2015)

Display equipment (0.09% of FY2025 revenue)

ProductDescriptionTarget customerNotesSource
HP/CP (hot plate / cool plate)Thermal units for drying/baking display glass in LCD/OLED processesSamsung Electronics/Samsung DisplayExclusive supplier since 2010 per IPO materials; now negligible revenueEdaily (2015); Alphasquare
Exposure equipment (노광기)Exposure tools for PCB, LCD and PDP manufacturingPanel and PCB makersListed as the first business purpose in the articles; TheVC lists "display exposure equipment" as the main productTheVC
OLED equipmentGeneral OLED process equipmentDisplay makersDescription onlyCompany summary (Alphasquare)

Electronic components (main constituent of "Other," ≈60% of FY2025 revenue)

ProductDescriptionTarget customerNotesSource
High-frequency coilsWound magnetic components for consumer/telecom electronicsElectronics OEMsHeritage of Daeshin Electronics (founded 1973)KIND; Saramin
TransformersPower/signal transformers ("민생용 및 통신기용 각종 코일, 변성기")Electronics OEMsProduced at the Gumi branch and Tianjin subsidiaryKIND
SMD inductorsSurface-mount inductorsElectronics OEMs—Saramin

Other businesses absorbed in 2025

BusinessDescriptionSource
Insulation materials (ex-Techron)Insulation material manufacturingKIND (merger note)
Electrical/vehicle-electronics equipment (ex-GET Plus)Electrical equipment ("전장장비") manufacturingKIND (merger note)

Bio / healthcare pipeline (no revenue disclosed)

Program areaModality / statusSource
Zika / MERS antiviralsDevelopment stage n/dSimply Wall St
GlaucomaDevelopment stage n/dSimply Wall St
Non-alcoholic fatty liver diseaseDevelopment stage n/dSimply Wall St
Chronic kidney diseaseDevelopment stage n/dSimply Wall St
Immunotherapy (cancer, inflammatory disease)Development stage n/dSimply Wall St
"Open-innovation bio platform"In-license / co-develop / license-out modelCompany summary (Alphasquare)

Proposed new businesses (pending EGM approval, 27 Oct 2026)

The articles amendment would add the following business purposes (company stated reason: "business diversification"):

  • service robots, humanoids/autonomous robots, drones/unmanned vehicles, robot components, robot control software and control platforms, robot-as-a-service (RaaS);

  • AI SaaS/cloud, AI agents, AI semiconductors and data centers, AI training data, and AI-based medical/financial/education/manufacturing solutions;

  • investment in, and acquisition of control over, AI and robotics companies.

Sources: Dealsite (Oct-2026); ChickStock DART summary (7 Oct 2026). TheVC also references AI ed-tech diversification. None of these generate revenue today.

Financial Narrative

Basis: K-IFRS consolidated. FY2021 data come only from Investing.com/S&P. FY2022–FY2025 come from DART-based disclosures (Edaily/Digital Today/Bizmetric) and Valueline/DataHero balance-sheet and P&L extracts. Where the as-originally-reported figure differs from the vendor/restated figure, the dossier uses the as-reported figure in the main table and shows the alternative below.

Income statement

Sources and notes:

  • FY2021: revenue, gross profit, operating income and attributable net income from Investing.com/S&P. Consolidated net loss is derived: FY2022 disclosure stated net loss of KRW 8.73 bn was a 61.3% improvement, implying ≈KRW -22.6 bn in FY2021.

  • FY2022: revenue KRW 20.11 bn, operating loss KRW 8.95 bn, net loss KRW 8.73 bn (Edaily, DART 30%-change disclosure, Feb-2023). Gross profit and attributable NI from Investing.com.

  • FY2023: revenue, operating loss and net loss from Bizmetric (DART quarterly series); gross profit and attributable NI from Investing.com.

  • FY2024: revenue KRW 33.52 bn and operating loss KRW 3.71 bn as originally reported (DART preliminary FY2025 disclosure comparatives); net loss KRW 7.82 bn. Gross profit is the restated figure (Investing.com).

  • FY2025: audited figures — revenue KRW 25.27 bn, operating loss KRW 0.83 bn, net loss KRW 15.72 bn (Alphasquare; Daily Union). P&L lines from Valueline (annual figure = 2025/12 trailing column). EPS KRW 4,706 (Valueline).

  • No dividends paid in any year (Stockopedia: the company does not pay a dividend).

Alternative/conflicting figures:

The FY2025 preliminary-to-audited swing is material. Operating loss widened from KRW 0.20 bn to KRW 0.83 bn, and net loss from KRW 9.93 bn to KRW 15.72 bn. This indicates sizeable year-end audit adjustments (Daily Union cites emphasis-of-matter and key audit matters).

Margins and growth

Notes: the FY2024 gross margin uses restated gross profit over restated revenue (5.31/27.13). FY2024 operating and net margins use as-reported revenue (33.52). Revenue CAGR FY2021–FY2025 = -13.6% p.a. (KRW 45.36 bn → KRW 25.27 bn).

EBITDA. Not reported by the company. Computed FY2025 EBITDA ≈ operating income (-0.83) + depreciation (0.98) + amortisation (0.18) ≈ KRW +0.33 bn (Valueline cash-flow add-backs). Valueline's own EBITDA field shows KRW -3.34 bn (definition unknown). EBITDA margin is ≈1% on the computed basis. Earlier years: n/d.

Recent quarterly trajectory

Sources: Google Finance (S&P-sourced). Bizmetric shows Q1 2026 net loss of KRW 4.0 bn on a consolidated basis. The Google Finance net line appears to be attributable to owners, and its Q4 2025 figure of KRW +27.1 bn reflects the parent/NCI allocation discussed below.

Trailing twelve months to June 2026 (Valueline): revenue KRW 22.72 bn; gross profit KRW 3.32 bn; SG&A KRW 9.39 bn; operating loss KRW 6.07 bn; consolidated net loss KRW 16.18 bn; attributable net income KRW +27.11 bn; NCI share KRW -43.30 bn; TTM attributable EPS KRW 5,255. SG&A jumped (TTM KRW 9.4 bn vs KRW 5.7 bn in FY2025), led by fees/commissions (KRW 2.5 bn) and salaries (KRW 3.9 bn). This coincides with the change-of-control and financing process.

The attributable-vs-consolidated anomaly (critical for valuation)

Since FY2024, THE CODI shows positive profit attributable to the parent but large negative profit attributable to non-controlling interests. In FY2025, consolidated net was KRW -15.7 bn, split into owners KRW +24.3 bn and NCI KRW -40.0 bn. NCI equity on the balance sheet has fallen to KRW -108 bn at FY2025 and KRW -113 bn at June 2026, while controlling-shareholder equity has risen to ≈KRW 118 bn.

Analyst interpretation (inference; not confirmed by company disclosure): losses are concentrated in consolidated SPVs where outside parties hold the economic residual. The real-estate fund/development vehicles and the CB-controlled Marine One are the likely candidates. Intra-group interest or valuation gains accrue to the parent. The consequence is that headline vendor metrics are economically misleading for the listed entity:

  • attributable EPS of KRW 4,706–5,255;

  • P/E of about 0.6–0.9x;

  • PBR of about 0.15x on controlling BPS of KRW 22,834;

  • "ROE" of 22–30%.

The consolidated group burns cash and its total equity is only KRW 4.7 bn.

Balance sheet

Sources: Valueline/DataHero consolidated balance sheet (FY2022–FY2025); Investing.com (FY2021 total assets and current liabilities). Share counts are split-adjusted (Valueline). Total debt = short-term borrowings + short-term bonds + current portion of long-term debt + long-term borrowings. It excludes lease/other financial liabilities of ≈KRW 2.3 bn at FY2025. Net debt = total debt – cash & equivalents.

Latest balance sheet (30 June 2026, KRW bn; Valueline). Total assets 74.43; cash 4.72; total liabilities 69.72; total equity 4.71; short-term borrowings 18.48; current portion of long-term debt 0.43; long-term borrowings 39.53. Total debt ≈ 58.44; net debt ≈ 53.72. Owners' equity 117.84; NCI -113.13. Development land 39.49. Controlling BPS KRW 22,834.

Key balance-sheet observations:

  1. Refinancing event in H1 2026. At FY2025, KRW 30.3 bn of long-term debt had moved into current liabilities. This drove the working-capital collapse to KRW 1.0 bn and a current ratio of about 1.0x. By June 2026 it had been refinanced into new long-term borrowings (cash-flow data show KRW 39.5 bn of new long-term borrowings in H1 2026 against KRW 29.9 bn repaid). Liquidity is extended, not resolved.

  2. Equity erosion. Total equity fell from KRW 38.0 bn (FY2022) to KRW 4.7 bn (June 2026), only ≈1.8x paid-in capital (KRW 2.58 bn). A further loss of a few billion won would push the consolidated group toward capital impairment.

  3. Asset quality. Development land (KRW 39.5 bn) is 53% of total assets. Its carrying value and realisability are the swing factor for solvency. Press reports say the land is tied to the former controlling family's real-estate projects, and that registered addresses of related vehicles could not be located (Seoul Economic TV, Jul-2025; Dealsite, Oct-2026).

  4. Accumulated deficit. Seoul Economic TV reported an accumulated deficit of KRW 49.2 bn and a liabilities-to-equity ratio of 285% at Q1 2025. The ratio was 572.5% at FY2025 (Alphasquare) and ≈1,480% at June 2026 (computed).

Cash flow

Sources: Daily Union (FY2024 and FY2025 OCF and investing CF, from DART); Valueline (FY2025 capex, financing CF). TTM to June 2026 (Valueline): OCF KRW -10.04 bn; capex KRW 1.22 bn; interest paid KRW 6.91 bn; financing CF KRW +6.38 bn. Valueline's "ending cash" field (KRW 23.6 bn at FY2025) is inconsistent with balance-sheet cash (KRW 6.17 bn) and has not been used.

Commentary. Operating cash flow has been negative in every period available. The FY2025 investing inflow came from liquidating short-term financial assets (KRW 11.3 bn of disposals; short-term financial assets fell from KRW 4.06 bn to KRW 0.68 bn), not from operations. Cash interest paid (KRW 3.7 bn in FY2025; KRW 6.9 bn TTM June 2026) exceeds gross profit. The company is structurally dependent on external financing (placements, CBs, re-sales of its own CBs) to service debt.

Ratios

Computation notes: averages use opening and closing balances. FY2024 asset turnover uses as-reported revenue. FY2025 interest expense is KRW 3.98 bn (Valueline). ROIC and the cash conversion cycle cannot be computed reliably because invested capital is distorted by development-land inventory and negative NCI. Net debt/EBITDA is not meaningful: on computed EBITDA of ≈KRW 0.33 bn it would be about 135x. Vendor-quoted ROE of 21.8–29.6% (Valueline, Alphasquare) corresponds to the owners' basis.

Trend synthesis. FY2021–FY2023 was a collapse: revenue fell 55%, gross margin turned negative, and operating losses reached about half of revenue. FY2024 marked an inflection in gross profit to ≈20% margin, attributable to consolidating the higher-volume components business (Daeshin Electronics) and cost cuts. FY2025 operating loss narrowed to near break-even (KRW -0.8 bn) on lower revenue. Below the operating line, however, interest (KRW 4.0 bn), impairments (KRW 3.5 bn), other non-operating losses and discontinued operations (KRW -8.0 bn) produced a doubling of the consolidated net loss. In H1 2026, operating performance deteriorated again (TTM operating loss KRW 6.1 bn) as SG&A rose with transaction costs.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Product Category Details

Product category (FY2025, % of consolidated revenue)FY2025

Other products etc. (%)

59.83

Semiconductor products (%)

40.09

Display products (%)

0.09

Product Category Details — Other products etc.

Product category (KRW Bn)FY2025

Other products etc.

15.12

Semiconductor products

10.13

Display products

0.02

Revenue by Segment

Metric (KRW Bn)FY2024 as originally reportedFY2024 restated (in FY2025 report)

Revenue

33.5227.13

Operating income

-3.71

-3.52 (Investing.com/S&P) or +0.25 (Daily Union)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Group Entities

EntityStakeActivity (as far as disclosed)Source

THE CODI Co., Ltd. (parent)

—

Semiconductor/display equipment; electronic components (Gumi branch, ex-Daeshin Electronics)

KIND

PharmaWorks Co., Ltd. (㈜파마웍스)

100.00%

Bio/drug development

WISEreport; KIND

Cellforium Co., Ltd. (㈜셀포리움)

70.00%

Bio (cell-based / therapeutics)

WISEreport; KIND

CODI-M VINA Corporation (Vietnam)

100.00%

Overseas subsidiary (function n/d)

WISEreport; KIND

Daeshin Electronics Tianjin (대신전연천진전자유한공사, China)

100.00%

Coils/transformers manufacturing (inferred from parent's former business)

WISEreport; KIND

GE Tech (지이테크)

100.00%—

WISEreport; KIND

E&K Consortium (이엔케이컨소시엄)

99.96%

Investment vehicle

WISEreport; KIND

Road One Real Estate Fund No.1 PEF (formerly Calvidon Real Estate Development Fund No.1)

99.49%

Real-estate development

WISEreport; KIND

Marine One Development (마린원개발㈜)

Controlled via potential voting rights on CBs held

Real-estate development

KIND; Seoul Economic TV

Kingdom Fore (㈜킹덤포레)

Subsidiary (stake n/d)

—

KIND

Associates: The First GM No.40, Song Kong Trading (쏭콩무역), Renaissance Avenue

Associates

—

KIND

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (KRW Bn, as reported)

45.3620.1120.2133.5225.27

Gross profit (KRW Bn)

-0.03-0.30-1.785.314.83

Operating income (KRW Bn, as reported)

-6.78-8.95-10.40-3.71-0.83

Pre-tax income from continuing ops (KRW Bn)

————-7.52

Loss from discontinued operations (KRW Bn)

————-8.00

Net income, consolidated (KRW Bn)

-22.57-8.73-13.70-7.82-15.72

Net income attributable to owners of parent (KRW Bn)

-27.11-14.10-7.9815.4624.28

Net income attributable to non-controlling interests (KRW Bn)

————-40.01

EPS basic, attributable (KRW)

————4,706

Dividends per share (KRW)

00000

Income Statement

Metric (KRW Bn)FY2022FY2023FY2024FY2025

Operating income per Investing.com/S&P

-11.17-9.96-3.52-0.31

Operating income per DART preliminary (Feb-2026)

——-3.71-0.20

Net income per DART preliminary (Feb-2026)

——-7.82-9.93

Net income per Investing.com (appears to be attributable)

-14.10-7.9815.4624.29

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue growth YoY (%)

—-55.70.565.8-24.6

Gross margin (%)

-0.1-1.5-8.819.619.1

Operating margin (%)

-14.9-44.5-51.5-11.1-3.3

Net margin, consolidated (%)

-49.8-43.4-67.8-23.3-62.2

Income Statement (Quarterly)

MetricQ3 2025Q4 2025Q1 2026Q2 2026

Revenue (KRW Bn)

6.405.125.215.99

Cost of goods sold (KRW Bn)

5.064.474.874.95

Operating income (KRW Bn)

0.24-0.58-3.92-0.91

Net income per Google Finance (KRW Bn)

0.5727.08-0.19-0.34

Balance Sheet and Share Count (M)

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (KRW Bn)

122.4993.6399.3994.0572.31

Current assets (KRW Bn)

—83.8276.9174.7259.77

Cash & equivalents (KRW Bn)

—14.4411.538.106.17

Short-term financial assets (KRW Bn)

—13.935.174.060.68

Trade receivables (KRW Bn)

—3.809.5710.515.30

Inventories, total (KRW Bn)

—49.2847.2847.8144.69

of which development land (KRW Bn)

—41.6739.6339.6339.49

Property, plant & equipment (KRW Bn)

—3.8214.8014.6510.83

Goodwill (KRW Bn)

—0000

Other intangibles (KRW Bn)

—0.300.990.870.30

Current liabilities (KRW Bn)

64.3923.7932.7834.6558.78

Total liabilities (KRW Bn)

—55.6767.2267.9961.55

Short-term borrowings (KRW Bn)

—12.0816.6520.3320.43

Short-term bonds (KRW Bn)

—1.803.8500

Current portion of long-term debt (KRW Bn)

—00.242.6130.33

Long-term borrowings (KRW Bn)

—29.9030.8730.410.08

Total debt (KRW Bn)

—43.7851.6153.3550.84

Net debt (KRW Bn)

—29.3440.0845.2544.67

Total equity (KRW Bn)

—37.9632.1726.0610.75

Equity attributable to owners (KRW Bn)

—46.9746.9393.92118.69

Non-controlling interests (KRW Bn)

—-9.00-14.76-67.86-107.94

Working capital (KRW Bn)

—60.0444.1340.080.99

Shares outstanding (M)

2.743.224.755.165.16

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (KRW Bn)

———-5.32-3.67

Investing cash flow (KRW Bn)

———-2.863.48

Capex, PP&E (KRW Bn)

————1.47

Free cash flow, OCF minus PP&E capex (KRW Bn)

————-5.14

Financing cash flow (KRW Bn)

————-1.75

Dividends paid (KRW Bn)

00000

Share buybacks (KRW Bn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025

ROE, consolidated, on average equity (%)

—-39.1-26.9-85.4

ROE, owners, on average owners' equity (%)

—-17.021.922.9

ROA, on average assets (%)

—-14.2-8.1-18.9

Current ratio (x)

3.522.352.161.02

Total debt / equity (x)

1.151.602.054.73

Total liabilities / equity (%)

146.6209.0260.9572.5

Interest coverage, EBIT / interest expense (x)

———-0.21

Asset turnover (x)

—0.200.350.30

Geographic Revenue

IndicatorObservationSource

Customer base

Principal equipment customers are Samsung Electronics and Samsung Display (Korea; Samsung lines in China were cited at IPO, e.g., Xi'an)

Aju News (Sep-2026); Edaily (2015)

Overseas operations

Manufacturing/sales subsidiaries in Tianjin (China) and Vietnam (CODI-M VINA)

WISEreport; KIND

FX exposure

FY2025 foreign-exchange gains of KRW 0.88 bn and losses of KRW 1.19 bn, indicating meaningful foreign-currency revenue and/or costs

Valueline

China expansion

At IPO the company targeted BOE and Tianma; no subsequent disclosure of material China panel-maker revenue

Edaily (2015)

Share Price and Market Valuation

MetricFY2022FY2023FY2024FY2025

Year-end share price (KRW)

9,4706,2504,0002,550

Year-end market cap (KRW Bn)

28.7429.6720.6413.16

Year-end shares outstanding (M)

3.224.755.165.16

Share Price & Returns

PeriodReturnBasis

Year-to-date 2026

≈+31%

KRW 2,550 (31 Dec 2025) → KRW 3,350 (19 Oct 2026)

≈3 years

≈-46%

KRW 6,250 (end-2023) → KRW 3,350 (approximate horizon)

5 years

Not meaningful (capital reduction, serial issuance)

—

52-week range

KRW 2,400 – 12,750

Hankyung

Drawdown from 52-week high

≈-74%

Judal (16 Oct 2026)

Valuation Snapshot

MultipleValueBasis / caveatSource

P/E (attributable TTM EPS KRW 5,255)

0.65x

Driven by negative-NCI allocation; consolidated group is loss-making

Valueline

P/E (consolidated)

Not meaningful (loss)

—

Computed

P/B (owners' BPS KRW 22,834)

0.15x

Owners' equity inflated relative to total equity

Valueline

P/B (total equity KRW 4.71 bn)

≈3.7x

Consolidated basis

Computed

EV/Sales

≈3.1x

EV ≈ market cap 17.5 + net debt 53.7 = KRW 71.2 bn; TTM sales KRW 22.7 bn; excludes NCI

Computed

Peer comparison

Sector median PBR 3.46x; median PER 21.6x (Korean semi equipment)

Alphasquare

—

Capital Markets

ItemStatusSource

Sell-side coverage / consensus

None. Only automated AI "research" sites (e.g., Judal) publish recommendations, which carry no institutional weight

Judal; Simply Wall St (no forecasts)

Dividend history / policy

No dividends paid; none expected

Stockopedia

Buyback authorisations

None disclosed; treasury stock ≈0.5%

iTooza

Moody's / S&P / Fitch ratings

Not rated

—

Bucket Details

BucketAmount (KRW Bn)

Short-term borrowings (<1 yr)

18.48

Current portion of long-term borrowings (<1 yr)

0.43

Long-term borrowings (>1 yr)

39.53

Lease and other financial liabilities

≈2.3

Analyst Conclusions

Management guidance and consensus

Guidance: none issued.

Consensus: none exists.

The only forward markers are the EGM (27 Oct 2026; a separate EGM is also convened for 29 Oct 2026), the 9th-CB resale settlement (29 Oct 2026), the still-pending KRW 7 bn Pantos placement, and the public-sale deadline (31 Dec 2026).

Bull case

  1. Credible control change. If Pantos pays the KRW 7 bn and takes ≈30% plus board control, the company gains a better-connected sponsor. The shares tripled in three sessions on this prospect alone (KRW 4,510 → 9,890, 7–10 Sep 2026).

  2. Operating leverage on a repaired gross margin. Gross margin is now ≈19% versus negative in FY2021–FY2023. An AI/HBM-driven Samsung capex upturn could lift equipment revenue back toward FY2021 levels (KRW 45 bn). At FY2025 SG&A (KRW 5.7 bn), that could restore operating profit.

  3. Asset monetisation. A sale of KRW 39.5 bn of development land at book value would roughly cover net debt (KRW 53.7 bn) together with other assets, transforming solvency against a KRW 17.5 bn market cap.

Bear case

  1. Financing failure. Since March 2026, every change-of-control financing has been amended, delayed, re-allotted or withdrawn: GNT Pharma, then the Keyence/SOD Lab vehicles, then K-New Growth Equity, then Pantos. The KRW 33 bn CB package was withdrawn in October. With cash of KRW 4.7 bn and OCF of KRW -10 bn TTM, the company cannot fund itself.

  2. Equity wipe-out risk. Total equity of KRW 4.7 bn covers only months of current losses (TTM net loss KRW 16.2 bn). Any write-down of the development land would eliminate it. Rescue capital, if it arrives, is priced at deep discounts (e.g., KRW 3,154 versus a pre-surge price of KRW 3,470).

  3. Governance and listing risk. The company has two prior unfaithful-disclosure designations (2020, 2023), a pending 2026 notice, related-party CB dealings under FSS review, a former-CEO misconduct allegation, and a largest shareholder whose capital is fully impaired. Accumulated penalties or financial thresholds could trigger KRX listing-eligibility review.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhat to watch
EGM(s)27 Oct and 29 Oct 2026Approval of Koo Bon-ho et al. as directors; robotics/AI articles; quorum
Pantos KRW 7 bn placement paymentPost-EGM (TBD)Actual cash receipt; change-of-control disclosure
9th-CB resale settlement29 Oct 2026KRW 3.15 bn balance received or further delay
KRX disclosure-penalty decisionsQ4 2026Penalty points; any listing-eligibility review
Q3 2026 quarterly reportMid-Nov 2026Equity level, operating loss, going-concern language
Public-sale deadline31 Dec 2026Completion or abandonment of the sale process
FY2026 auditMar 2027Audit opinion; land valuation; capital-impairment status
Samsung memory/HBM capex2026–2027Any disclosed equipment orders (single-sales-contract disclosures)
FSS review of related-party CB saleOpenSanctions or referrals

Analyst verdict

THE CODI should not be analysed as a semiconductor-equipment company that happens to be cheap. It is a heavily indebted, governance-impaired holding vehicle whose only genuine operating asset is a sub-scale, Samsung-dependent tool and components business. That business generated KRW 25.3 bn of revenue in FY2025, down 44% from FY2021, and roughly break-even operating results before interest. Everything below the operating line is what matters, and all of it is negative:

  • interest costs consume more than gross profit;

  • operating cash flow has been negative throughout the observable period;

  • consolidated equity has fallen to KRW 4.7 bn against KRW 69.7 bn of liabilities.

The apparently compelling valuation (0.65x P/E, 0.15x P/B) is an artefact of loss allocation to non-controlling interests in consolidated real-estate and investment vehicles. It should be disregarded. On a consolidated basis, the equity is priced at about 3.7x book with negative earnings, and enterprise value is ≈3x trailing sales of a shrinking business.

The investment debate therefore reduces to a binary governance event. Will a well-funded sponsor actually inject capital, take control and either (a) monetise the land and recapitalise the group or (b) reverse-merge a real operating business into the listing? The record of the past seven months is unambiguous. Four successive control-change financings, including the high-profile Pantos/Koo Bon-ho deal, have been amended, delayed or withdrawn. Every rescue structure has relied on deeply discounted shares or convertible paper that would multiply the share count.

Until cash is verifiably received, the risk/reward is asymmetric to the downside: dilution, disclosure sanctions, possible listing-eligibility review, and land-value write-downs. Verdict: Avoid / speculative only. The stock is suitable at most for event-driven traders sized for total loss. Re-assess only after (1) settlement of the Pantos placement, (2) a FY2026 audit without going-concern qualification, and (3) independent evidence on the carrying value of the KRW 39.5 bn development-land inventory.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleTenure / datesBackground / notesSource

Choi Hyun-joon (최현준)

CEO, inside director

CEO since Mar 2025; re-elected 31 Mar 2026

Bought 4,500 shares on-market shortly before the Sep-2026 control-change disclosures

WISEreport; JobPost

Jin Jong-pil (진종필)

Vice President

—

Bought 6,010 shares on-market (Sep-2026)

JobPost

Jeon Kyung-woo (전경우)

Director

Re-elected Mar 2026

—

WISEreport

Choi Cheong-kyun (최청균)

Outside director (audit committee per TheVC listing)

Appointed Oct 2023; re-elected Mar 2026

—

WISEreport

Joo Hae-jung (주해중)

Inside director

Appointed Oct 2023

—

WISEreport

Former: Hwang Jung-hoon (황정훈)

CEO

Jun 2020 – Mar 2025

Subject of a KRW 360 M embezzlement/breach-of-trust allegation disclosed April 2025

Saramin; WISEreport

Former: Sujit Thomas Varghese (TJ Varghese)

Director

Feb 2024 – Mar 2025

—

WISEreport

Former: Moon Yong-bae (문용배)

CEO

to Jun 2020

—

Saramin

Former: Lee Woo-suk (이우석)

CEO at IPO

c. 2015

Led 2015 IPO

Edaily (2015)

Former: Kim Sun-tae (김선태)

Vice President (bio)

c. 2017–2018

Former co-CEO of Kangstem Biotech

BioSpectator

Board of Directors

NameProposed roleNotesSource

Oh Il-sung (오일성)

Inside director

—

ChickStock (DART); Dealsite

Koo Bon-ho (구본호)

Inside director

Third-generation member of the extended LG family; chairman of Pantos Holdings; 100% owner of Pantos Corporation

Dealsite; Global Economic

Kim Sung-il (김성일)

Inside director

Co-principal of Pantos Corporation per Seoul Economic Daily

Seoul Economic Daily

Ahn Soo-kyung (안수경)

Independent director

—

ChickStock (DART)

Kim Jong-hyun (김종현)

Independent director

—

ChickStock (DART)

Governance Overview

FeatureStatus

Independent / outside directors

At least one outside director (Choi Cheong-kyun); audit committee members listed in the registry (TheVC)

Committees

Audit committee (per registry entries for 감사위원); others n/d

Board size change

The EGM articles amendment changes the number of directors (details n/d)

Major Shareholders

HolderStakeNotesSource

Iseok Industrial Development (이석산업개발)

≈12% (press, Sep-2026); ≈1.09 M shares ≈21% including related parties (Seoul Economic TV, Jul-2025)

Largest shareholder since May 2022. 50% owned by Park Ran-hee, spouse of Cho Sung-ok (former Sambu Construction chairman). Capital fully impaired: equity KRW -6.89 bn at end-2025 (Lead Economy)

Global Economic; Dealsite; Lead Economy

Minority (retail) shareholders

78.83% held by 17,084 holders (30 Jun 2026)

Implies largest shareholder plus related parties ≈21%

Lead Economy

Foreign ownership

0.00%

Foreign exhaustion rate 0% during Sep-2026 trading

JoongAng Economy News

Treasury shares

≈0.5%

—

iTooza

Institutional holders (top 10)

Not publicly disclosed; no meaningful institutional ownership evident

——

Share-Based Incentives

InstrumentCounterpartySizeTermsStatusSource

Third-party placement

Pantos Corporation

KRW 7.0 bn; 2,219,403 shares

KRW 3,154/share; ≈43% of existing shares; ≈30.1% post-deal

Payment delayed repeatedly (22 Sep → 7 Oct → further delay)

Dealsite; Seoul Economic TV

10th-series CB

Pantos Corporation

KRW 3.0 bn

—

Not paid; withdrawn

Dealsite (Oct-2026)

11th-series private CB

Investment unions (some linked by press to former Cornerstone Networks chairman Cho Yun-hyung)

KRW 30.0 bn

Conversion KRW 3,550; ≈8.45 M shares

Not paid; withdrawn

Dealsite; JobPost

Small public offering (third-party)

Power M Entertainment (replacing Greylock Investment Union)

KRW 1.5 bn; 317,863 shares

Price cut from KRW 8,772 to KRW 4,719

Payment set for 12 Oct; postponed per Dealsite

Dealsite

Resale of own 9th-series CB

Pacific Wave Union

KRW 3.5 bn face

887,198 shares on conversion; KRW 0.35 bn deposit + KRW 3.15 bn balance

Balance now due 29 Oct 2026

ChickStock (DART)

Competitive Landscape

Competitors by Segment

BusinessCompetitorCountryPositioning vs. THE CODI

Wafer cleaning / coat-develop (track)

SEMES (Samsung Electronics subsidiary)

Korea

Captive in-house Samsung supplier of cleaning/track tools; structurally advantaged at THE CODI's main customer

Wafer cleaning / coat-develop (track)

Tokyo Electron

Japan

Global leader in coater/developer and cleaning

Wafer cleaning

SCREEN Holdings

Japan

Global leader in single-wafer/batch cleaning

Wafer cleaning / wet process

Zeus Co., Ltd.

Korea

KOSDAQ-listed wet-process/cleaning tool maker with materially larger scale

Wet process / CMP-cleaning

KC Tech

Korea

Larger domestic peer in wet/CMP equipment

Display thermal / heat-treatment (HP/CP)

Viatron Technologies

Korea

Heat-treatment equipment for display

Display exposure

Mycronic

Sweden

Named by TheVC as a peer in display exposure (mask writers)

Display laser/processing

Aton ENG; Osung Advanced Materials

Korea

Named by TheVC as comparable small display-equipment companies

Coils / transformers / inductors

Samwha Electronics; Chinese and Taiwanese magnetics makers

Korea / Asia

Commodity, price-driven market; THE CODI is a niche player

Back-end bonding

Hanwha Semitech; Hanmi Semiconductor

Korea

Large-scale back-end equipment suppliers (HBM-related TC bonders)

Peer Comparison FY2025

MetricTHE CODI (FY2025)Tokyo Electron (FY3/2025)SCREEN Holdings (FY3/2025)

Revenue

KRW 25.3 bn

≈JPY 2.43 tn

≈JPY 625 bn

Revenue growth

-24.6%

strong double-digit growth (n/v)

double-digit growth (n/v)

Operating margin

-3.3%

≈28% (n/v)

≈20%+ (n/v)

R&D intensity

—

≈10% (n/v)

—

Competitive Advantages & Vulnerabilities

Advantages (evidence)Vulnerabilities (evidence)

Long qualification history at Samsung: HP/CP supply since 2010, bonding tools since 2015 (Edaily)

Scale: KRW 25 bn revenue; peers are 10–1,000x larger (Alphasquare ranking)

Diversified revenue via components (≈60% of FY2025 revenue) reduces dependence on fab capex

Display line has collapsed to 0.09% of revenue (Alphasquare)

Owns land and buildings (KRW 6.9 bn land in PP&E; Valueline)

No disclosed R&D spend; no disclosed product roadmap

—

Balance-sheet fragility limits customers' willingness to award large tool orders

—

Management bandwidth absorbed by financing and control transactions

Company Snapshot

$17.8M

Revenue

30

Employees

1999

Founded

Cheonan, South Korea

Headquarters

SWOT Analysis

Strengths

  • Samsung qualification heritage. Exclusive HP/CP supplier to Samsung Electronics since 2010 and bonding-equipment supplier since 2015 (Edaily IPO, Dec-2015); Samsung remains the principal equipment customer (Aju News, Sep-2026).
  • Gross-margin repair. Gross margin improved from -8.8% (FY2023) to 19.6% (FY2024, restated) and 19.1% (FY2025) (Investing.com; Valueline).
  • Near-break-even operating result in FY2025. Operating loss narrowed to KRW 0.83 bn from KRW 10.4 bn in FY2023 (Alphasquare; Bizmetric).
  • Diversified revenue base. Components and other products made up 59.83% of FY2025 revenue, cushioning equipment cyclicality (Alphasquare).
  • Hard-asset backing. Development land of KRW 39.5 bn plus land of KRW 6.9 bn and buildings of KRW 3.7 bn in PP&E (Valueline, FY2025).
  • Owner-level book value far above market value. Owners' equity of KRW 117.8 bn vs. market cap of KRW 17.5 bn (Valueline, June 2026). This is accounting-driven; see Weaknesses.

Weaknesses

  • Chronic losses. Operating losses every year since FY2016 (Seoul Economic TV). Consolidated net losses in each of FY2021–FY2025, totalling ≈KRW 68.5 bn (§6.1).
  • Thin consolidated equity. Total equity of KRW 4.71 bn at June 2026, against total liabilities of KRW 69.72 bn (Valueline).
  • Negative cash generation. OCF of KRW -5.32 bn (FY2024), KRW -3.67 bn (FY2025) and KRW -10.04 bn TTM June 2026 (Daily Union; Valueline).
  • Interest burden exceeds gross profit. FY2025 interest expense of KRW 3.98 bn vs. gross profit of KRW 4.83 bn; TTM cash interest paid of KRW 6.91 bn vs. gross profit of KRW 3.32 bn (Valueline).
  • Financial-reporting reliability. The FY2025 audited net loss (KRW 15.72 bn) was 58% larger than the preliminary figure (KRW 9.93 bn), and the audit report contained emphasis-of-matter paragraphs (Digital Today; Daily Union).
  • Complex structure with negative NCI. NCI of KRW -113 bn at June 2026 shows that consolidated vehicles carry large losses borne outside the parent. Owner-level metrics are therefore unreliable for valuation (Valueline).
  • Sub-scale with negligible R&D disclosure. Ranks 135th of 152 Korean semiconductor equipment companies by revenue (Alphasquare).

Opportunities

  • Change of control to a better-capitalised owner. If the KRW 7 bn Pantos placement completes, Pantos would hold ≈30.1% and board control (Dealsite).
  • AI/HBM capex cycle. Memory makers are planning capacity additions around 2027 (Financial News). Re-qualification of THE CODI's cleaning/bonding tools could benefit.
  • Monetisation of development land. A sale of the KRW 39.5 bn land inventory could deleverage the group (Valueline). Timing and value are n/d.
  • Bio pipeline licensing. Programs in NAFLD, CKD, glaucoma and immunotherapy (Simply Wall St) could be out-licensed or sold.
  • KOSDAQ semiconductor re-rating. The sector's index weight reached 25.2% in June 2026 (Financial News), and thematic flows lift small equipment names.
  • Robotics/AI business purposes. These would give flexibility to acquire operating businesses if credible financing is secured (Dealsite).

Threats

  • Dilution overhang. The withdrawn KRW 30 bn CB alone would have created ≈8.45 M shares (164% of outstanding) (JobPost). Further CB/placement attempts are likely.
  • Regulatory sanctions. The company was a repeat unfaithful-disclosure designee in Sep-2020 and Jan-2023 (13.5 points; KRW 54 M fine), received a new designation notice in 2026, and faces more CB withdrawals (Dealsite; BizWatch; Daily Union). Accumulated penalty points can trigger a listing-eligibility review.
  • Failure of the control transaction. Pantos payments have been postponed repeatedly. Pantos was set up in July 2026 with KRW 10 M of capital (Seoul Economic Daily).
  • Related-party / insider-dealing scrutiny. Own-CB sales to related parties at par or without disclosure (2023, 2024), and the FSS said it would review (Asia Economy; Green Economy).
  • Refinancing risk. Total debt of ≈KRW 58.4 bn against cash of KRW 4.7 bn at June 2026 (Valueline).
  • Customer concentration and captive competition. Dependence on Samsung, which sources cleaning/track tools from its own subsidiary SEMES (industry structure).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Former CEO Hwang Jung-hoon faces embezzlement/breach-of-trust allegation (KRW 360 M) SaraminGovernance red flag
15 May 2025Q1 2025 report: revenue KRW 8.8 bn, net loss KRW 2.8 bn; liabilities/equity 285%; accumulated deficit KRW 49.2 bn; Techron and GET Plus mergers noted as subsequent events KIND; Seoul Economic TVBaseline deterioration
4 Jul 2025Press investigation: sale process stalled; deadline extended to end-2025; affiliated investment vehicles untraceable at registered addresses; active fund flows with the Cho Sung-ok family Seoul Economic TVCredibility of asset base questioned
Aug 2025H1 2025: revenue KRW 13.7 bn; operating income KRW 0.3 bn; net loss KRW 5.3 bn BizmetricTemporary operating break-even
Nov 2025Q3 2025: 9M revenue KRW 20.1 bn; operating income KRW 0.1 bn; net loss KRW 6.0 bn Bizmetric—
23 Feb 2026Preliminary FY2025: revenue -24.6% to KRW 25.27 bn; operating loss KRW 0.20 bn; net loss KRW 9.93 bn; discontinued operation recognised Digital Today/NateHeadline loss narrowed (later revised)
12 Mar 2026Decision to resell the 9th CB (KRW 3.5 bn) to Pacific Wave Union ChickStockLiquidity raise; potential dilution of 887,198 shares
~20 Mar 2026Press: earlier (Nov-2024) resale of KRW 3 bn own CB to related party Park Jun-sik without disclosing the relationship; FSS says it will review Green EconomyPossible disclosure / insider-dealing issue
Mar 2026FY2025 audit: unqualified opinion with emphasis of matter / KAMs (Daehyun); audited net loss KRW 15.72 bn; equity KRW 10.75 bn Daily UnionAudited loss 58% larger than preliminary
31 Mar 2026AGM re-elects CEO Choi and directors WISEreportBoard continuity
Apr 2026GNT Pharma placement (largest-shareholder change) scheduled for 15 Apr payment Green EconomyFirst control-change attempt of 2026
15–17 Apr 2026Placement payment delayed to 19 May; allottees changed to SOD Lab SPV No.1 (two investors, KRW 1 M capital) and Keyence No.1 Union; bio plant and acquisition delayed IB TomatoFunding risk
Jun 2026KOSDAQ semiconductor sector overtakes healthcare as the largest by market cap (25.2% share) Financial NewsFavourable sector tailwind for valuation
7 Aug 2026Share price around KRW 3,360; market cap KRW 17.3 bn Google FinancePre-deal baseline
Aug 2026Q2 2026: revenue KRW 5.99 bn; operating loss KRW 0.91 bn Google FinanceOngoing losses
~Aug 2026KRW 1.5 bn third-party small public offering to Greylock Investment Union approved MyDailyByteSmall liquidity raise
7 Sep 2026KRW 30 bn 11th-series CB approved (163.75% of outstanding shares) Google Finance; Daily UnionMassive potential dilution
8 Sep 2026Placement allottee changed to Pantos Corporation (Koo Bon-ho); stock limit-up to KRW 5,860 Global Economic; JoongAng Economy NewsChange-of-control catalyst
9–10 Sep 2026Two further limit-ups (KRW 7,610; KRW 9,890; turnover KRW 10.3 bn on 10 Sep) JoongAng Economy NewsSpeculative surge
~Sep 2026KRX notice of intent to designate an unfaithful-disclosure corporation (disclosure changes) Daily UnionRegulatory risk
10 Sep 2026Press: Pantos placement price (KRW 3,154) is about one-third of the market price; Pantos is a paper company registered at Koo's apartment, capitalised at KRW 10 M in July 2026 Lead Economy; Seoul Economic DailyDeal-quality concerns
10 Sep 2026Press: 13 executives bought shares in the ten days before the control-change disclosure TheVC (news aggregation); JobPostInsider-trading optics
16–17 Sep 2026Board calls a separate EGM for 29 Oct 2026 (record date 2 Oct; agenda TBD) Digital TodayGovernance calendar
23–29 Sep 2026Corrections: small-offering allottee changed to Power M Entertainment (equity KRW -72 M); price cut to KRW 4,719 Dealsite; Lead EconomyWeak counterparties
1 Oct 2026Pantos payment re-scheduled to 7 Oct; EGM set for 8 Oct DealsiteDelay
5 Oct 2026Placement and CB payments pushed beyond the EGM date; the original payment date (10 Apr) is close to the 6-month change threshold that triggers unfaithful-disclosure penalties Seoul Economic TVRegulatory exposure
6–7 Oct 2026Press: CB investors and director candidates linked to former Cornerstone Networks chairman Cho Yun-hyung; questions over who will actually control the company DealsiteGovernance opacity
7 Oct 2026EGM postponed to 27 Oct 2026 ChickStock (DART)Delay
13 Oct 2026Stock +8.8% intraday to KRW 3,815 on no confirmed news JobPostVolatility
~14 Oct 2026KRW 33 bn of CBs (10th and 11th) withdrawn after non-payment; Pantos placement payment postponed again DealsiteDeal at risk; likely further disclosure penalties
15 Oct 20269th-CB resale balance (KRW 3.15 bn) payment moved to 29 Oct ChickStockLiquidity timing
16 Oct 2026Close KRW 3,395 (+6.43%) Hankyung—
19 Oct 2026Close KRW 3,350 (-1.33%); market cap KRW 17.5 bn ValuelineCurrent valuation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Segment (FY2025): Other products etc. was KRW 15,120 Mn in FY2025.
THE CODI Co., Ltd. — Revenue by Segment (FY2025)
Series (KRW Mn)FY2025
Other products etc.15,120
Semiconductor products10,130
Display products20

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Simply Wall St — THE CODI Co., Ltd. company page and analysis (simplywall.st)
  2. Stockopedia — The Codi Co share price page (stockopedia.com)
  3. Google Finance — 224060:KOSDAQ (EN/KR) · google.com
  4. WISEreport (기업모니터) — company overview, history, affiliates (comp.wisereport.co.kr)
  5. Valueline/DataHero — balance sheet, income statement, cash flow · valueline.co.kr · valueline.co.kr
  6. Investing.com — financial summary (S&P data) (investing.com)
  7. Bizmetric — DART quarterly series (bizmetric.co.kr)
  8. Alphasquare — stock summary, sales mix, sector ranking (alphasquare.co.kr)
  9. iTooza — company page (itooza.com)
  10. TheVC — company profile (thevc.kr)
  11. Saramin — company registry history (saramin.co.kr)
  12. KIND/KRX — Q1 2025 quarterly report excerpt (kind.krx.co.kr)
  13. Digital Today / Nate — FY2025 preliminary results disclosure (Feb-2026) (m.news.nate.com)
  14. Digital Today — EGM convocation (29 Oct 2026) (digitaltoday.co.kr)
  15. Daily Union — FY2025 financial condition and CB dilution (Sep-2026) · dailyan.com
  16. Dealsite — Pantos deal and CB structure (Oct-2026) · CB withdrawals · Cho Yun-hyung links · 2020 unfaithful-disclosure designation
  17. Global Economic — Pantos limit-up (Sep-2026) (g-enews.com)
  18. Newspim — Pantos limit-up (newspim.com)
  19. Aju News — new high, customers (ajunews.com)
  20. JoongAng Economy News — 8, 9, 10 Sep 2026 price moves · joongangenews.com · joongangenews.com
  21. JobPost — consecutive limit-ups and executive purchases (Sep-2026) · 13 Oct 2026 trading
  22. Lead Economy — placement price, shareholder base (leadeconomy.co.kr)
  23. Seoul Economic Daily — Pantos as paper company · payment delays
  24. Seoul Economic TV — stalled sale, untraceable vehicles (Jul-2025) · payment delays (Oct-2026)
  25. ChickStock — DART summaries (EGM amendment 7 Oct 2026; own-CB sale amendment 15 Oct 2026) · chickstockfi.com
  26. Green Economy — related-party CB sale, FSS review (Mar-2026) (greened.kr)
  27. IB Tomato / News Tomato — 2026 funding delays · 2023 largest-shareholder issuance · Sambu link · disclosure penalties
  28. Asia Economy — 2023 CB sale to largest shareholder (core.asiae.co.kr)
  29. BizWatch — Jan-2023 unfaithful-disclosure designation (news.bizwatch.co.kr)
  30. Edaily — 2015 IPO interview · FY2022 results · record FY2017 revenue
  31. BioSpectator — 2017–18 bio pivot and name change (biospectator.com)
  32. Newsis — Dec-2017 KRW 10 bn placement (mobile.newsis.com)
  33. Financial News — 2020 M&A process · KOSDAQ semiconductor weight (Jun-2026)
  34. Sidae — 2017 Philosys rally (sidae.com)
  35. Hankyung Korea Market — price data (markets.hankyung.com)
  36. Judal — price/drawdown data (16 Oct 2026) (judal.co.kr)
  37. Wikipedia — Samsung Display (LCD exit 2022) (en.wikipedia.org)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.